Comparison

Vatalanib dihydrochloride European Partner

Item no. TMO-T6720-200mg
Manufacturer TargetMol
CASRN 212141-51-0
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9978
Citations 1. Wood JM, et al. Cancer Res. 2000, 60(8), 2178-2189.
Smiles Cl.Cl.Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias CGP-797870 dihydrochloride,ZK-222584 dihydrochloride,PTK787 dihydrochloride,Vatalanib 2HCl,Vatalanib (PTK787) 2HCl,CGP-79787 dihydrochloride
Shipping Condition Cool pack
Available
Manufacturer - Targets
PDGFR|||VEGFR|||Apoptosis
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
419.73
Description
Vatalanib dihydrochloride (PTK787 dihydrochloride)(IC50=37 nM) is an inhibitor of VEGFR2/KDR. It exhibits less effective against VEGFR1/Flt-1 and 18-fold against VEGFR3/Flt-4.
Pathways
Angiogenesis|||Apoptosis|||Tyrosine Kinase/Adaptors

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close